CochLear (OTCMKTS:CHEOY) Shares Gap Up – Time to Buy?

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOYGet Free Report) gapped up prior to trading on Monday . The stock had previously closed at $47.40, but opened at $50.31. CochLear shares last traded at $50.31, with a volume of 7,661 shares.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Royal Bank Of Canada lowered CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 target price for the company. in a report on Thursday, July 16th. Jefferies Financial Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, July 22nd. Zacks Research raised CochLear from a “strong sell” rating to a “hold” rating in a research report on Monday, June 22nd. Finally, Canaccord Genuity Group cut CochLear from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 18th. Five research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, CochLear currently has an average rating of “Hold” and an average price target of $117.00.

Get Our Latest Report on CHEOY

CochLear Stock Performance

The firm has a 50 day moving average price of $46.11 and a two-hundred day moving average price of $46.02.

CochLear Company Profile

(Get Free Report)

Cochlear Limited is an Australian medical device company that develops, manufactures and supplies implantable hearing solutions. Its products are designed for people with severe to profound hearing loss who may not receive sufficient benefit from conventional hearing aids.

The company’s portfolio includes cochlear implants, bone conduction hearing implants, and related sound processors, accessories, software and support services. Cochlear also provides rehabilitation resources, clinical support and ongoing product services intended to help recipients use and maintain their hearing systems.

Founded in 1981 and headquartered in Sydney, Australia, Cochlear serves customers through a global network spanning Australia, New Zealand, North America, Europe, Asia and other international markets.

See Also

Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.